🇺🇸·3h agoRegulatory
BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION
Publisher
F
FDA Drug Safety Communications
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- FDA Drug Safety Communications
- Region
- USA
- Scope
- Regulatory
- Published
- July 25, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on fda.gov
Leave the platform to read the original full article on the publisher site.
Source: FDA Drug Safety Communications
Scope: Regulatory
Related coverage
More related coverage
FDA Drug Safety Communications/9h ago
Sunny Pharmtech, Inc. Issues Voluntary Nationwide Recall of Cyclophosphamide for Injection, USP to the User Level Due to the Presence of Particulate Matter
UK Department of Health and Social Care/10h ago
Working for DHSC
We offer a varied, exciting, challenging and rewarding working environment.
UK Health Security Agency/10h ago
Meningococcal B (MenB) time limited vaccination offer: eligibility flow chart
Guidance for health professionals delivering the time-limited MenB vaccination offer on the eligible...
LEEM France/11h ago